Popular on Rezul
- Instant DSCR Term Sheet Now Available in ChatGPT for Real Estate Investors - 256
- Houston Market Report Q3 2026 | Industrial Distribution - 254
- Wappler Capital Expands Investment Platform Into Georgia - 250
- ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains - 244
- Cays Realty Launches AI-Powered South Florida Property Search Platform - 209
- Pulte announces Canopy Cove, Pulte's first-ever townhome community in St. Johns County - 205
- CompStak Launches Agent Connect, an MCP Server for Verified Commercial Real Estate Data - 202
- The Enclave at Winslow Fulfills an Important Role in South Jersey's Housing Market - 189
- Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry - 184
- NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event - 171
Similar on Rezul
- Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
- Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
- Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
- Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
- ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
- HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
- Meta Partnership Expanding as Omni One Orders Surge 3X -New Consumer Bundles, Defense Opportunities & AI Robotics: Virtuix Holdings: N A S D A Q: VTIX
- Acuvance Survey Finds ERP Integration Remains a Key Challenge as Healthcare Organizations Prepare for AI
- Industrial & systems engineering educator and professional to lead global strategic partnerships for professional society
- Convergence of AI, Wearable Technology, Remote Patient Monitoring and Real-World Healthcare: PomDoctor Ltd. (N A S D A Q: POM)
Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results
Rezul News/10674132
TEMECULA, Calif. - Rezul -- 16Revolutionary Anti-Aging Breakthrough Unveiled: Telomere Technology and Telos95 Offer Promising Results
TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.
Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.
Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."
More on Rezul News
Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.
"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."
For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.
TEMECULA, CA – July 16, 2024 - In a groundbreaking development poised to redefine anti-aging treatments, researchers at the Salk Institute have introduced cutting-edge Telomere Technology alongside Telos95®, a clinically proven anti-aging supplement targeting cellular aging. Telos95® consists of a plant-based blend of highly therapeutic polyphenols naturally isolated from grapevine and organic olive leaf.
Telos95®'s phytochemical compounds fight free radicals, nourishing cells with nutrients that promote telomere and cellular longevity, effectively slowing down the aging process of healthy cells. This supplement not only halts the shortening of telomeres but has been shown to lengthen them, reducing cellular age by an average of 7.43 years in just 6 months.
Abdul Alkayali, Vice President of Sales at Longevity by Nature, explains, "Our clinical studies demonstrate that Telos95® protects telomeres, slows cellular aging, and enhances longevity. By harnessing the power of natural polyphenols, we aim to redefine how we approach aging and age-related illnesses."
More on Rezul News
- Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee
- Tax Tops the List as Wealthy Brits Plan Their Exit, La Vida Survey Finds
- Hampton Roads Inventory Hits Six-Year High: Capital Valuations Issues Seller Advisory
- "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026
- Detroit Lawyer Steals $600,000 Settlement Meant to Protect Child
Telomere Technology, in conjunction with Telos95®, offers potential benefits in reducing the need for therapies to treat age-related illnesses such as cancer, cardiovascular problems, eye diseases, and inflammatory conditions. Moreover, Telos95® can be prescribed to insurance customers who have undergone telomere testing, showing promise in stopping or reversing telomere shortening with regular use.
"In our human study," Abdul Alkayali continues, "participants who consumed Telos95® daily experienced significant reductions in their TeloYear Age, demonstrating the supplement's efficacy in promoting cellular health and wellness."
For more information on Telos95® visit Telos95: Telomere Lengthening Anti-Aging Supplement (longevitybynature.biz), and on Telomere Technology, visit Anti-Aging Telomere Tech | Worldhealth.net Anti-Aging News.
Source: Longevity by Nature
0 Comments
Latest on Rezul News
- How to Choose a Heating Repair Company in Philadelphia
- Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
- BluBay by ORA Land Is Redefining Mumbai 3.0 Real Estate
- AI Agents Are Getting Their Own Computers. HRTech Leading in Vertical Harness Development
- What Austin First-Time Home Buyers Should Know with Mortgage Rates at 7.40%
- UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
- GreenPoint Roofing Seeks Northern Colorado Veteran for 9th Annual Veterans Day Roof Replacement Donation
- Bob + Molly Hamrick Receive 2026 Coldwell Banker Preserving the Trust Award
- American Quarter Horse Association Signs Lease at Lawndale Shopping Center in Amarillo, Texas
- Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
- M/I Homes celebrates grand opening of new model home at Turnleaf
- Corner Property Management AAMC Expands Presence with Clover Mill Management Agreement
- AutoProIT Achieves Cyber Essentials Certification, Reinforcing Its Commitment to Secure Digital Transformation
- DayPass llega a ChatGPT y Claude
- DayPass launches in ChatGPT and Claude
- Renkeer Water Quality Sensors Support Efficient Operation of AI Liquid Cooling Systems
- Victor Archibong Expands ItsArchiDuh Creator Brand
- Apple Valley Home Sales Fall 10.6% as Active Listings Decline 22.2% in September 2026
- Parade of Homes Winners Announced
- ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
